cGMP Process Solutions and Equipment

Integrated PMA Pharma Matrix™ Mixer / Granulator 300 and MP Multi-Processor™ 4/5 fluid bed Processor

GEA Pharma Systems is a world leader in providing technically advanced process solutions for liquid processes and for solid dosage forms to the pharmaceutical and biotechnology industries. Based on a dedication to research and by utilizing good engineering practices and the latest CAD techniques, GEA Pharma Systems offers a wide range of solutions, from individual pieces of equipment to complete integrated plants, by uniting the state-of-the-art technologies of Aeromatic, Buck, Collette, Courtoy, Fielder, Lyophil, Nica and Niro.

Our expanded staff of knowledgeable experts is always willing to help with equipment selection, specification, and design.

Our major products and technologies include:

• PharmaSD™ (PSD) pharmaceutical spray dryer
• Aeromatic-Fielder fluid bed processors
• FlexStream™ Fluid Bed Processing
• GEA Lyophil cGMP lyophilizers (freeze dryers)
• Fielder PMA and Collette Gral high-shear mixer-granulators (granulation /agglomeration)
• Collette Ultima™ one-pot processors (mixers and one pot processors)
• Buck® Systems intermediate bulk containers, blenders, and wash stations
• Buck® Valve Containment Interfaces
• Rotary tablet presses
• Aeromatic-Fielder PharmaConnect®
• Nica™ extruders and spheronizers (Pelletizing)
• Precision Coater™ (Patented)
• Precision Granulation™ (Patented) - a new process for granulation, agglomeration and coating
• Standard Single Use CIP/ WIP System
• Collette Consigma™ continuous high shear granulation and drying system
• GEA Pharma Systems Lighthouse Probe™ Technology

For a full listing of products and detailed information, see our "Products" section.

Formerly known as the Aeromatic-Fielder Division, GEA Pharma Systems was formed in 2000 after Niro acquired additional pharmaceutical equipment technology through its parent company GEA-AG's acquisition of the Pharmaceutical Division of GEI International plc. This added new expertise and advanced capabilities in materials handling, tablet processing, and enhanced containment systems. In November 2005 GEA acquired the Freeze Drying Division of Steris GmbH and renamed the company GEA Lyophil. GEA Lyophil joined the other pharma companies in GEA Pharma Systems. Due to the success and the and rapid expansion of the GEA Process Engineering Segment it was in December 2007 / January 2008 decided to split the Division into the GEA Process Engineering Segment and the GEA Pharma Division. At the same time the brand and the business unit changed name from GEA Pharma Systems as GEA Pharma Systems.

Innovation - not just for its own sake but for improved products, greater safety and enhanced productivity to deliver a better tomorrow.

For GEA Pharma Systems, innovation is the key to our success and to continued prosperity for our customers. In fact it's more than that. We know that by continually stretching the boundaries of what is possible in pharmaceutical processing we have the ability to support our customers in enhancing the opportunities available to millions of people all over the world. This is what drives our business. Our innovation takes many forms and affects all parts of the process. We innovate to increase production and reduce costs, to improve containment and safeguard the workforce, to achieve better clinical effectiveness and to enhance quality control. At GEA Pharma Systems the innovation never stops - it's just part of what we do. Innovation - not just for its own sake but for improved products, greater safety and enhanced productivity to deliver a better future.

For inquiries outside the US and additional information, please visit GEA Pharma Systems.